ACM Global Central Laboratory Continues to Invest in European Presence

York, England, July 27, 2009 – ACM Global Central Laboratory, the global central laboratory that continually defines the customer-service standard with its flexible approach, have announced the appointment of Theresa Thackray, head of Business Development, Europe. Theresa has more than nine years experience in the central laboratory industry and is responsible for building a professional sales team and continuing to cultivate relationships with ACM Global’s current clients. Along with expanding the business in the areas of Europe, Israel and South Africa, with particular emphasis on growth within the countries of Central and Eastern Europe, Theresa will be responsible for proposal and marketing efforts in Europe.

“Theresa brings extensive knowledge and experience to our expanding global sales team,” said Jerry Boxall, managing director of ACM Global, Europe. “The demand for clinical laboratory services are still growing and I am confident Theresa’s expertise will further enhance ACM Global’s reputation for providing a team of experienced and dedicated professionals.”

This significant appointment comes just months after ACM Global Central Laboratory, based in Rochester, NY, announced the acquisition of its long-term partner Pivotal Laboratories, based in York, England, which allows the unified group to continue its impressive record of growth and enhance its service offering on a global basis.

“Europe is a very important region for conducting clinical trials and we boast a wealth of experience in this area,” said Elena Logan, VP of Global Clinical Trials, ACM Global. “A strategic hire such as this, demonstrates our commitment to further strengthening our position in the industry.”

About ACM Global Central Lab

ACM Global Central Lab offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM’s operations extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting.

For more information, visit www.acmgloballab.com.

Back to news